Avadel Pharmaceuticals plc
Sector: Manufacturing
Industry: Pharmaceutical Products
7.85
-0.09
(-1.13%)
Volume:
973,128
52 week range:
7.39 - 19.09
Market Cap:
756.438M
Company Description:
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.